SonoThera
Signal active
Organization
Contact Information
Overview
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.
About
Industries
Biotechnology, Medical, Biopharma, Genetics
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
SonoThera headquartered in United States, North America, operates in the Biotechnology, Medical, Biopharma, Genetics sector. The company focuses on Biotechnology and has secured $972.0M in funding across 16 round(s). With a team of 11-50 employees, SonoThera is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - SonoThera, raised $60.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
11
Lead Investors
0
Total Funding Amount
$60.8M
Details
1
SonoThera has raised a total of $60.8M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 60.8M |
Investors
SonoThera is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Brian Halak | - | FUNDING ROUND - Brian Halak | 60.8M |
| Medical Excellence Capital | - | FUNDING ROUND - Medical Excellence Capital | 60.8M |
| SonoThera | - | FUNDING ROUND - SonoThera | 60.8M |
| Eli Lilly & Company Foundation | - | FUNDING ROUND - Eli Lilly & Company Foundation | 60.8M |
Recent Activity
There is no recent news or activity for this profile.